Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations

von Wyl, Viktor; Yerly, Sabine; Böni, Jürg; Shah, Cyril; Cellerai, Cristina; Klimkait, Thomas; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Furrer, Hansjakob; Hirschel, Bernard; Vernazza, Pietro L; Ledergerber, Bruno; Günthard, Huldrych F; Swiss HIV Cohort Study, (2012). Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. Clinical infectious diseases, 54(1), pp. 131-40. Cary, N.C.: Oxford University Press 10.1093/cid/cir728

[img]
Preview
Text
cir728.pdf - Published Version
Available under License Publisher holds Copyright.

Download (275kB) | Preview

Estimates of drug resistance incidence to modern first-line combination antiretroviral therapies against human immunodeficiency virus (HIV) type 1 are complicated by limited availability of genotypic drug resistance tests (GRTs) and uncertain timing of resistance emergence.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Furrer, Hansjakob

ISSN:

1058-4838

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:24

Last Modified:

23 Oct 2019 04:45

Publisher DOI:

10.1093/cid/cir728

PubMed ID:

22057700

Web of Science ID:

000298383500026

BORIS DOI:

10.7892/boris.8251

URI:

https://boris.unibe.ch/id/eprint/8251 (FactScience: 213767)

Actions (login required)

Edit item Edit item
Provide Feedback